Wastewater surveillance is becoming increasingly critical for community health monitoring for detecting COVID-19 outbreaks and the spread of other infectious diseases Collaboration combines QIAcuity digital PCR instruments and sample preparation from QIAGEN with GT Molecular’s highly sensitive SARS-COV-2 wastewater assay Joint solution launched in August sets new standards, in particular, speed to results in less […]
Glasgow, UK: REPROCELL Europe Ltd, a subsidiary of REPROCELL Inc., has signed a non-exclusive distributorship agreement with Helicon Company, one of the leading suppliers of research equipment and consumables in Russia. For more than 20 years, Helicon Company has been supporting researchers working in molecular biology and diagnostics. This new agreement aims to broaden the reach of REPROCELL products […]
“A Genome for Basuki” will Crowd-source Funds to Sequence and Assemble the Critically Endangered Banggai Cardinalfish Genome SCOTTS VALLEY, Calif. — Dovetail Genomics, the world-leader in high-quality de novo genome assembly, and Revive & Restore, the leading wildlife conservation organization promoting the incorporation of biotechnologies into standard conservation practice, announced today a new partnership that will accelerate […]
QIAGEN and OncXerna enter into a global master agreement to advance the development of the Xerna™ TME panel as a potential Next Generation Sequencing (NGS) companion diagnostic for OncXerna’s Navicixizumab Agreements include a non-exclusive license for QIAGEN to the OncXerna Xerna™ TME panel The agreements broaden QIAGEN’s NGS companion diagnostics capabilities in immuno- oncology clinical […]
CAMBRIDGE, Mass. & SOUTH SAN FRANCISCO, Calif. — Ultivue, Inc. and Fluidigm Corporation (Nasdaq:FLDM) today announced a co-marketing agreement in which the companies will offer customers a comprehensive portfolio of workflow solutions for biomarker discovery and drug development. Ultivue, a leader in advancing precision medicine solutions by accelerating tissue biomarker discovery and validation develops unique […]
Objective of Agreement is Comprehensive Portfolio for Biomarker Discovery and Drug Development SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a co-marketing agreement with Ultivue, Inc., under which the companies will offer a comprehensive portfolio of solutions for […]
Collaboration Focusing on Advancing CRO Capabilities in Drug Development Utilizing the Hyperion Imaging SystemSOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a collaboration and co-marketing agreement with ImaBiotech for service offerings and product development for Imaging Mass Cytometry™ […]
DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, has commenced a project with the University of Cambridge’s Innovation Centre in Digital Molecular Technologies (iDMT), an open innovation research centre co-funded by the University of Cambridge, AstraZeneca, Shionogi, and the European Regional Development Fund. DeepMatter will provide its DigitalGlassware® platform to iDMT as part of the […]
UNIVERSITY OF PITTSBURGH INVESTS IN CANOPY BIOSCIENCES’ CHIPCYTOMETRY INSTRUMENT FOR SPATIAL BIOLOGY
High-Plex Single-Cell Imaging to Accelerate Immunology Research ST. LOUIS, Missouri — Canopy Biosciences, a Bruker Company, today announced that the University of Pittsburgh will add ChipCytometry™ for high-plex single-cell spatial biology to its capabilities at the Unified Flow Core in the Department of Immunology. ChipCytometry will be used to advance spatial biology research by quantifying cell […]
Molecular Cartography™ platform features leading microscopy and 3D imaging capabilities JENA and MONHEIM AM RHEIN, Germany | ZEISS Research Microscopy Solutions Resolve Biosciences, the pioneer in Molecular Cartography™, and ZEISS today announced a co-development collaboration to advance spatial biology applications. The companies are working together to optimize advanced microscopy and 3D imaging solutions for subcellular spatial […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
